Alantra

📰 This morning, we hosted a group of leading financial journalists at our Madrid offices for a session on Equity Capital Markets, featuring a deep dive into the #IPO process. The event was held in collaboration with the Spanish Association of Financial Journalists (Asociación de Periodistas de Información Económica), the Spanish Stock Exchange (BME | Bolsas y Mercados Españoles), and Cox, a leading water and energy utility that Alantra recently advised on a successful IPO as Joint Bookrunner. The session explored how and why companies go public, highlighting the role of different market participants throughout the process. It was introduced by Macarena Muñoz, Reporter at Bloomberg and President of APIE, and featured insights from Alvaro Castro, Head of Primary Markets at BME, Andre Pereira-Ambrosio, Head of #ECM Iberia at Alantra, and Ignacio Moreno, CEO of COX, who shared first-hand learnings from the company’s IPO journey. Thank you all for such an engaging and insightful discussion on the behind-the-scenes of the famous bell-ringing listing ceremony and on how capital markets can be a long-term ally for value creation in companies! 🔔 📈 #AlantraECM #CapitalMarkets #FinancialJournalism

Alantra has acted as exclusive financial advisor to Outcomes First Group (OFG) on the carve-out and sale of its adult residential services division to Achieve together, one of the UK’s leading providers of specialist support for autistic people and individuals with learning disabilities. Richard Cooke Investment and Strategy Officer at Outcomes First Group, commented: “We have known the Alantra team for over a decade and had no hesitation in appointing them to support us on this complex carve-out. Their deep sector knowledge, hands-on technical capabilities and process experience delivered an outstanding result for us in an efficient time frame.” Justin Crowther, Managing Director and Head of UK Healthcare at Alantra, added: “We are delighted to have advised Outcomes First Group on the strategic carve-out of their adult residential care division. Outcomes First Group has a market-leading reputation supporting people with complex needs, and in Achieve together we have found them a responsible partner who will continue to provide high-quality care and person-centred support to the adults now in their care. This is a great outcome for all concerned.” Alantra’s longstanding relationship with OFG, combined with its deep sector expertise and track record in executing complex carve-outs, enabled the successful and efficient delivery of this transaction. The deal team included Justin Crowther, Matthew Kumeta and Thomas Tett. Read more: https://lnkd.in/dWVbif2S #Healthcare #SpecialistCare #CarveOut #FinancialAdvisory

🗽 Jacobo Llanza Figueroa, Executive Chairman of Alantra Asset Management, had the pleasure of participating in the #SpainMBAConference at Columbia Business School last week. As the birthplace of Value Investing, Columbia was the perfect setting for Jacobo’s session on the topic, after which he introduced Alantra’s friendly activist fund, EQMC, and presented Alantra’s other services in Asset Management, highlighting the Firm's investment philosophy and approach. Great discussions and an inspiring exchange with the next generation of finance leaders! 🚀 #Alantra #InvestmentStrategy #ColumbiaBusinessScool

Alantra is pleased to announce the successful completion of the Accelerated Bookbuilding (ABB) of CLINICA BAVIERA’s shares. Alantra acted as the sole Global Coordinator in the placement of 1,304,606 shares, representing 8% of the company’s share capital, at a price of €32.50 per share, raising a total of approximately €42.4mn. Andre Pereira-Ambrosio, Partner and Head of ECM at Alantra Equities, said: “We are pleased to have supported Clínica Baviera and its shareholders in this successful placement, which opens a new phase for Clinica Baviera as a listed entity on the back of the free float increase and the diversification of Baviera’s investor base. This transaction reflects the strong investor appetite for quality capital markets opportunities in the small and mid-cap space. With proper investor education and extensive marketing, high quality issuers like Clinica Baviera are capable of attracting capital at competitive prices. This was a joint effort with our Milan team, and a landmark transaction for Alantra, which actively engaged with over 50 investors to build a well-balanced book.” This transaction underscores Alantra’s momentum in advising on high-profile Equity Capital Markets transactions in Iberia. Recently, the firm acted as Co-Lead Manager for HBX Group’s IPO and Joint Bookrunner for Cox’s IPO on the Madrid Stock Exchange. Read more: https://lnkd.in/dDBcaUwb The Spanish deal team also featured Pedro Garnica, Nelson Cruz, Diego Miranda, Gonzalo Picazo Mur, Alberto Rodriguez Garcia, Oscar Sanchez Rios, Diogo Cabral and Álvaro Lenze, and on the Italian side Andrea Russo, Filippo Codazzi, and Gianpiero Di Perna, CFA. #ECM #AcceleratedBookbuilding #Healthcare

Alantra is pleased to announce that it has advised Affidea Group, a leading pan-European provider of specialist healthcare services including cancer care, advanced diagnostic imaging and community-based polyclinics, on the acquisition of Uroviva Group, Switzerland’s foremost urology network, from German Equity Partners IV, a fund managed by independent German investment company ECM Equity Capital Management, and Uroviva Group’s founding physicians. Christopher Jobst, Managing Director at Alantra, said: “We are pleased to have advised Affidea in this successful transaction. The partnership with Uroviva creates a highly complementary platform with a leading market position in Switzerland and we look forward to seeing what it achieves in its next phase of growth.” André Hüneburg, Director at Alantra, added: “Our team provided senior M&A advisory throughout the entire process, leveraging our deep expertise of the DACH healthcare services industry to provide Affidea with unique access to the sellers and navigate the transaction towards a successful outcome for both parties.” Marc-Andre Christinat, CEO of Affidea Switzerland said: “With Uroviva joining our network, we are not only doubling our footprint in the country but also creating a leading national platform for integrated oncology care. It is not just a strategic expansion, it’s a commitment to our patients, doctors and the communities we serve. We appreciated Alantra’s collaborative approach throughout the process, supporting a smooth and efficient transaction that sets the foundation for long-term value creation.” Razvan Predica, Chief Commercial Officer for Affidea Group, added: “This transaction reflects our continued focus on high-impact growth opportunities that align with Affidea’s strategy of building integrated, specialist care platforms across Europe. Alantra’s deep sector knowledge, strong execution capabilities and strategic input were key points in delivering a successful outcome on this important acquisition for us”. This transaction underscores Alantra’s expertise in the healthcare sector, building on the recent advisory of KIRKBI A/S on its investment in AMBOSS, Oakley Capital on the strategic combination of WINDSTAR MEDICAL GROUP and Merz Lifecare, and Trill Impact on its partnership with TT medic Group. Read more: https://lnkd.in/d9BjcbxH #Healthcare #FinancialAdvisory 

A recent article on AdviserVoice Pty Limited features insights from Francisco De Juan, Managing Partner and CIO of Alantra’s EQMC strategy, on why having “a reasonable influence and oversight of portfolio companies (not control) should help better investment outcomes”. Alantra’s EQMC strategy follows this philosophy by acquiring significant minority stakes - typically around 20-25% - to actively engage with management while maximizing shareholder value. The award-winning fund focuses on listed small and mid-cap companies with global reach and has achieved double-digit net annualized returns since its inception in January 2010. As Francisco notes, “these returns are comparable to those you can obtain in private equity, but we believe we can obtain them with less risk.” The fund has outperformed indexes by 170% to 220%+ and most hedge funds, all while maintaining controlled risk, a small net cash position, and no leverage. EQMC continues to focus on sectors with resilient business models and predictable cash flows. Its portfolio of 12 to 15 companies is managed by an investment team that is held to strict value metrics for its investments. Looking ahead, Francisco highlights that “European small-cap valuations are very cheap, and we expect them to improve shall interest rates decline (or simply stabilize), and M&A activity picks up.” Read more in the full article: https://lnkd.in/eJtS6TnT

Michael Lenoce, CFA and Carter Nichols will be in Las Vegas next week to attend the Directions North America conference. The event brings together key players in the Microsoft Dynamics ecosystem. Our team looks forward to engaging with Microsoft Partners to discuss M&A market trends and offer strategic advice on how to optimize their businesses to maximize valuation.   Will you be there? Reach out to Michael or Carter to connect!   #MicrosoftDynamics #DirectionsNA #BusinessCentral #MergersAcquisitions 

Last week at #HBI2025, Ángel Manotas, Managing Director at Alantra Private Equity, joined a panel discussion moderated by Rakshitha Narasimhan (Healthcare Business International) alongside Dr. Marco MAZEVET (Candesic), Sara Dalmasso (Straumann Group), Neil Carmichael (The Association of Dental Groups), and Anni Seaborne (Bupa Dental Care UK) to explore how investment in oral healthcare can drive better health outcomes and reduce costs.   Alantra Private Equity has been actively investing in the sector, acquiring multiple dental laboratories to build Digitaldent, the second-largest dental laboratory group in Spain. The dental market remains highly fragmented, presenting significant opportunities for consolidation, efficiency gains, and technological advancements.   AI and digitalization are transforming the industry, enhancing diagnostics, streamlining workflows, and improving patient care. With strong sector tailwinds and increasing demand, oral healthcare presents a compelling investment opportunity.   Many thanks for having us, #HBI2025!

Jeremy P.G. Hermant, Senior Advisor at Alantra and Significant Risk Transfer (SRT) specialist, was interviewed in the podcast Credit to the Nation, hosted by Dentons. The episode focused on key developments in the EU’s SRT market, and Jeremy shares insights on: 📈 Key regulatory changes in the EU SRT market 💲 Practical hurdles for first-time SRT issuances by U.S. regional banks 💼 His career journey from derivatives trader to expert SRT-er and the best entry points for new SRT-ers looking to get into the industry Tune in to gain expert perspectives on the evolving SRT market! 🎧 Listen the full episode here: https://lnkd.in/eCWnjNzh #SRT #FIG #Podcast 

Pierre-Alain Rikkers, Managing Director at Alantra, is attending TRANSACT Show 2025 this week, the leading payments event of the year held in Las Vegas, Nevada. The event, powered by the Electronic Transactions Association, brings together the brightest minds and the best ideas and innovations reshaping the future of payments. Feel free to reach out to Pierre-Alain if you’d like to connect! #TRANSACT2025 #FinTech